UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Journal of clinical oncology, 2016-03, Vol.34 (7), p.661-668

2016

Volltextzugriff (PDF)

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials

International journal of molecular sciences, 2022-06, Vol.23 (13), p.7222

2022

Volltextzugriff (PDF)

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6832

2022

Volltextzugriff (PDF)

Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?

International journal of molecular sciences, 2022-07, Vol.23 (13), p.6936

2022

Volltextzugriff (PDF)

NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6748

2022

Volltextzugriff (PDF)

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10803

2023

Volltextzugriff (PDF)

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11495

2023

Volltextzugriff (PDF)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6477

2022

Volltextzugriff (PDF)

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.606-613

2015

Volltextzugriff (PDF)

Clinical Effectiveness and Cost-effectiveness of Target Therapies for Adult Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: A Systematic Review

Current cancer drug targets, 2018-01, Vol.18 (5), p.405-409

2018

Volltextzugriff (PDF)

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

Frontiers in oncology, 2024-02, Vol.14, p.1307458

2024

Volltextzugriff (PDF)

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation

International journal of molecular sciences, 2022-06, Vol.23 (13), p.7322

2022

Volltextzugriff (PDF)

EML4-ALK Variants and Co-Occurring TP53 Mutations in a Real-World Treatment Setting: Do They Matter?

Journal of thoracic oncology, 2024-11, Vol.19 (11), p.1489-1491

2024

Volltextzugriff (PDF)

Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-04, Vol.88 (5), p.1114-1119

2014

Volltextzugriff (PDF)

Hepatocellular Carcinoma in HIV‐Infected Patients: Check Early, Treat Hard

The oncologist (Dayton, Ohio), 2011-09, Vol.16 (9), p.1258-1269

2011

Volltextzugriff (PDF)

Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion

Current oncology (Toronto), 2023-11, Vol.30 (11), p.10033-10042

2023

Volltextzugriff (PDF)

Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma

Journal of clinical oncology, 2006-03, Vol.24 (9), p.1443-1448

2006

Volltextzugriff (PDF)

Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings

Radiologia medica, 2020-02, Vol.125 (2), p.214-219

2020

Volltextzugriff (PDF)

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer

Recent patents on anti-cancer drug discovery, 2019-01, Vol.14 (3), p.242-257

2019

Volltextzugriff (PDF)

Treatment of elderly patients affected by lung cancer: why to treat, when to treat and what we know

Anti-cancer agents in medicinal chemistry, 2013-11, Vol.13 (9), p.1378-1382

2013

Volltextzugriff (PDF)

Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

BMC research notes, 2016-07, Vol.9 (1), p.349-349, Article 349

2016

Volltextzugriff (PDF)

Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4663-4669

2007

Volltextzugriff (PDF)

Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4577-4577

2017

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(146)

Publikationsform

Artikel
(160)
Berichte
(2)

Sprache

Englisch
(162)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(100)
Science & Technology
(100)
Humans
(89)
Oncology
(79)
Male
(57)
Female
(56)
Middle Aged
(49)
Aged
(47)
Adult
(43)
Lung Neoplasms - Drug Therapy
(43)
Chemotherapy
(42)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(37)
Lung Cancer
(34)
Aged, 80 And Over
(33)
Treatment Outcome
(30)
Lung Neoplasms - Pathology
(28)
Metastasis
(27)
Cancer Therapies
(25)
Tumors
(25)
Mutation
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study

Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications

Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?

NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications

Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors

Clinical Effectiveness and Cost-effectiveness of Target Therapies for Adult Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer: A Systematic Review

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation

EML4-ALK Variants and Co-Occurring TP53 Mutations in a Real-World Treatment Setting: Do They Matter?

Stereotactic Body Radiation Therapy for Re-irradiation of Persistent or Recurrent Non-Small Cell Lung Cancer

Hepatocellular Carcinoma in HIV‐Infected Patients: Check Early, Treat Hard

Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion

Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma

Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer

Treatment of elderly patients affected by lung cancer: why to treat, when to treat and what we know

Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

Cisplatin Plus Gemcitabine or Vinorelbine for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The MILES-2P Studies

Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP)

Suchergebnisse filtern